Skip to main content

Short Bowel Syndrome clinical trials at University of California Health

2 research studies open to eligible people

Showing trials for
  • Registry for Participants With Short Bowel Syndrome

    open to all eligible people

    This is a global prospective, observational, multi-center registry to evaluate the long-term safety profile for participants with short bowel syndrome (SBS) who are treated with teduglutide in a routine clinical setting. The registry will also evaluate the long-term clinical outcomes in participants with SBS. SBS participants treated and not treated with teduglutide will be enrolled.

    at UCLA UCSF

  • Trial to Evaluate Efficacy and Safety of Apraglutide in SBS-IF

    open to eligible people ages 18 years and up

    The primary objective of the trial is the confirmation of the efficacy of apraglutide to evaluate the efficacy of weekly subcutaneous apraglutide in reducing parenteral support dependency.

    at UCLA

Our lead scientists for Short Bowel Syndrome research studies include .

Last updated: